Table III. Univariate and multivariate analysis for recurrence-free survival of patients undergoing adjuvant S-1 chemotherapy for biliary tract cancer.

CA19-9: Carbohydrate antigen 19-9; GLIM: Global Leadership Initiative on Malnutrition; HR: hazard ratio; LN: lymph node; pap: papillary adenocarcinoma; UICC: Union for International Cancer Control classification seventh edition; well: tubular adenocarcinoma, well-differentiated. Statistically significant p-values are shown in bold.